1 | RA | 70 | Female | SSZ 2 g/day | No | 8 | 81.5 | 59 | 19 | 4.446 |
2 | RA | 59 | Female | MTX 7.5 mg/week | No | 4 | 22.4 | 38 | 6.1 | 9.338 |
3 | RA | 36 | Female | MTX 7.5 mg/week, SSZ 2 g/day | MP 4 mg/day | 4 | 58 | 49 | 16.4 | 9.7382 |
4 | RA | 51 | Female | SSZ 2 g/day | No | 8 | 18.1 | 46 | 4.9 | 5.780 |
5 | RA | 62 | Female | MTX 7.5 mg/week | No | 4 | 20.9 | MD | MD | 12.673 |
6 | RA | 67 | Male | No | No | 17 | 110.8 | 95 | 20.6 | 6.67 |
7 | RA | 23 | Female | No | MP 8 mg/day | 4 | 3 | 8 | 0.3 | 8.3375 |
8 | RA | 52 | Male | MTX 15 mg/week | No | 84 | 8.8 | 13 | 33.3 | 12.5 |
9 | RA | 29 | Female | No | No | 24 | 54 | 61 | 11.5 | 8.671 |
10 | RA | 70 | Female | MTX 10 mg/week | No | 120 | 44 | 58 | 10.4 | 10.005 |
11 | RA | 52 | Female | No | No | 1.5 | 96.4 | 53 | 12.5 | 8.9378 |
12 | SpA (IBD) | 30 | Female | No | No | 96 | MD | MD | MD | 6.67 |
13 | SpA (PsA) | 66 | Male | MTX 7.5 mg/week | No | 8 | 6.8 | 10 | 0.1 | 7.005 |
14 | SpA (Juv) | 21 | Male | SSZ 2 g/day | MP 4 mg/day | 48 | 11 | 7 | 11.8 | 7.337 |
15 | SpA (PsA) | 60 | Female | MTX 15 mg/week | MP 4 mg/day | 25 | 7 | 9 | 25 | 7.6038 |
16 | SpA (PsA) | 33 | Female | MTX 7.5 mg/week, SSZ 2 g/day | No | 60 | 3.2 | 13 | MD | 8.671 |
17 | SpA (PsA) | 65 | Female | MTX 15 mg/week | No | 120 | 69 | 65 | MD | 9.338 |
18 | SpA (AS) | 41 | Male | No | No | 192 | 14 | 17 | 6.5 | 9.338 |
19 | SpA (AS) | 48 | Male | SSZ 6 g/day | No | 12 | 43 | 41 | 25.2 | 7 |
20 | OA | 60 | Male | No | No | 31 | MD | MD | MD | 7.8706 |
21 | uA | 53 | Male | No | No | MD | 7 | 9 | 9.6 | 5.780 |
22 | uA | 29 | Female | No | No | 2 | MD | MD | MD | 5.336 |
23 | uA | 46 | Female | No | No | 6 | MD | MD | 2.7 | 7.333 |
24 | uA | 64 | Female | No | No | 82 | 97.9 | 77 | 16.9 | 7 |